PDCI’s PMPRB Guidelines Modernization Webinar Session
On June 24, the PMPRB released its long awaited consultation paper “PMPRB Guidelines Modernization – Discussion Paper, June 2016”. The paper, the initial phase of a three-part Guideline modernization process, asserts that PMPRB’s current framework is outdated and seeks feedback on a wide range of issues that will inform changes to the PMPRB’s Excessive Price Guidelines. Although the paper suggests that the PMPRB “has no preconceptions about the specific changes that may result from this process” it is evident from the report’s background analysis that the PMPRB has already concluded that Canadian drug prices are too high and that the current Guidelines are inadequate. The deadline for responses to the PMPRB discussion paper is October 24, 2016.
PDCI Market Access Inc., Canada’s leading pricing and reimbursement consultancy, will be hosting FREE information webinar sessions on August 17th and 23rd 2016, from 10:00 a.m. to 12:00 p.m. (noon). The sessions will be presented and led by Neil Palmer, President & Principal Consultant at PDCI.
The webinar sessions are to create awareness of what’s coming up and to show how manufacturers can make adjustments to their product pipelines. The sessions will include: background, timelines, insight into the potential Guideline changes contemplated by the PMPRB and outline of the potential impact and implications of the potential changes to prices of patented medicines in Canada.
This webinar session is directed to manufacturers and industry only.
Participants can sign up for one or both sessions. Details on registration will be posted soon through TargetPharma and on the PDCI website (www.pdci.ca). For more information, please visit our website or contact Sierra Palaniyandi at 613-742-8225 ext. 34.
Can’t attend the webinar sessions and/or would prefer a customized in-house session? Please contact Neil Palmer (Neil.Palmer@pdci.ca) or Kaitlyn Proulx (Kaitlyn.Proulx@pdci.ca) for more details.